<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the efficacy of Xianlong Capsule (XLC) in treating the senile vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Forty-six cases of VD were randomly divided into two groups </plain></SENT>
<SENT sid="2" pm="."><plain>The XLC group (24 patients) were treated with XLC and the control group (22 patients) were treated with Hydergine </plain></SENT>
<SENT sid="3" pm="."><plain>Mini-mental state examination (MMSE), Hamilton <z:hpo ids='HP_0000716'>depression</z:hpo> scale (HDS) marks and clinical symptoms were observed in different groups </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: XLC could markedly increase MMSE and HDS marks of VD patients </plain></SENT>
<SENT sid="5" pm="."><plain>XLC had the effect of improving balance and gait ability of VD patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: XLC had certain effect on VD and its effect was better than that of Hydergine </plain></SENT>
</text></document>